MELISSA HICKMAN: Open Payments
NPI 1518920107 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 66 payments from 8 companies in 2025. Trend: 2023 $1,444 · 2024 $1,803 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 21 | $411 |
| Supernus Pharmaceuticals, Inc. | 12 | $314 |
| Collegium Pharmaceutical, Inc. | 14 | $312 |
| Neurocrine BioSciences, Inc. | 7 | $176 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Tris Pharma Inc | 5 | $84 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Noven Therapeutics, LLC | 1 | $22 |
Products named: Azstarys, Qelbree, Jornay PM, INGREZZA, Dyanavel XR, ABILIFY MAINTENA, Auvelity, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
